Experimental studies have demonstrated that albumin therapy had a variety of neuroprotective effects, such as improving neurological function and reducing the volume of cerebral infarction and brain edema in animals with AIS (Belayev et al., 2001, 2005). This evidence concerns the gene ALB and cerebral infarction.